MS

Michael Stavinsky

Investor at Glade Brook Capital Partners

New York, New York

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $1,000,000.00
  • Target Investment:

    $550,000.00

Work Experience

  • Investor

    2022

    Global technology growth equity.

2020 - 2022

  • Investment Banking Analyst

    2020 - 2022

    Healthcare group - experience across multiple sub-verticals (HCIT, Healthcare Services, MedTech, Life Sciences, etc.) on strategic M&A and capital markets transactions. Selected Transaction Experience: - Exclusive financial advisor to Curia on its acquisition of LakePharma (July 2021) - Financial advisor to Charlesbank on its significant investment in Symplr (July 2021) - Sole bookrunner for LAVA Medtech Acquisition Corp.'s IPO (October 2021) - Exclusive placement agent for HealthCare.com on its oversubscribed financing round (December 2021) - Exclusive financial advisor to Enquire Solutions on its sale to Rubicon Technology Partners (October 2022)

2019 - 2019

  • Investment Banking Summer Analyst

    2019 - 2019

    Healthcare group

2017 - 2018

  • Wealth Management Intern

    2017 - 2018

    Tamar Securities is a privately owned wealth management firm that specializes in growth and income oriented equity portfolios as well as municipal debt markets. Using both fundamental and technical analysis, the company follows a discipline centered around market "Super Cycles" to effectively monitor portfolios based in equities and fixed income indexes. - Managed equity portfolio centered around the thesis of the fourth industrial revolution (autonomous vehicles, AI/ML, 5G internet, AR/VR, cloud-computing, etc.) - Conducted research on equities and presented / discussed investment ideas

2017 - 2018

  • Co-Founder

    2017 - 2018

    Offered on-campus organizations an e-commerce solution for designing and manufacturing apparel.

2014 - 2016

  • Lifeguard

    2014 - 2016

2015 - 2015

  • Sales Marketing Representative

    2015 - 2015